Columnist Halsey Blocher, who lives with SMA, feels a sense of connection with a Christmas movie's depiction of a disabled princess.

Nearly 4 of every 5 infants in Italy born with SMA type 1 since the approval of disease-modifying therapies (DMTs) are alive, ...

Columnist Ari Anderson has set a goal for 2025: to multiply the chances of good things coming his way each time they happen.

Natalie Katz, MD, is an assistant professor of pediatrics in the division of neurology at Duke University and co-directs the Duke Children’s Neuromuscular Program, which provides comprehensive ...

An algorithm may help predict the risk of scoliosis in patients who have received disease-modifying SMA treatment, a study ...

Spinal muscular atrophy (SMA) is a genetic, progressive disease that affects the nervous system and muscles. The life expectancy for people with SMA depends on the type of their disease and symptom ...

Spinal muscular atrophy (SMA) is a rare genetic condition resulting in symptoms that most commonly include progressive muscle weakness and poor muscle tone. While motor function is typically most ...

The SMA Europe project has patients sharing their story of how SMA treatment affects their lives with goal of better access ...

Swallowing function may have improved in spinal muscular atrophy (SMA) patients since disease-modifying therapies (DMT) have ...